PTPRC and leukemia: PDX cells were inoculated intravenously into NOD/SCID mice, and leukemia engraftment and progression were assessed weekly by determining the percentage of circulating human CD45+ (huCD45+) leukemia cells as a proportion of total CD45+ cells (Figure 3A).